Screener
AdaptHealth AHCO Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by AdaptHealth in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: AdaptHealth’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030602
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Payments relating to the Tax Receivable Agreement | (26,846) | (25,012) |
| Distributions to noncontrolling interests | (1,522) | (2,046) |
| Payments for tax withholdings from vesting of restricted stock units | (2,367) | (1,324) |
| Net cash provided by (used in) financing activities | 52,562 | (56,039) |
| Net decrease in cash | (58,172) | (56,097) |
| Cash at beginning of period | 106,136 | 109,747 |
| Cash at end of period | $47,964 | $53,650 |
| Supplemental disclosures: |
Item 1. Interim Consolidated Financial Statements (Unaudited)
FAQ
- What is AdaptHealth's financing cash flow?
- AdaptHealth (AHCO) reported financing cash flow of $52.56M in Q1 2026.
- How has AdaptHealth's financing cash flow changed year-over-year?
- AdaptHealth's financing cash flow increased by 193.8% year-over-year, from -$56.04M to $52.56M.
- What is the long-term trend for AdaptHealth's financing cash flow?
- Over 4 years (2021 to 2025), AdaptHealth's financing cash flow has grown at a -34.3% compound annual growth rate (CAGR), from $1.62B to -$302.19M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about AdaptHealth's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude